What structure does a Retroperitoneal fibrosarcoma arise from?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

A retroperitoneal fibrosarcoma arises from the fibrous connective tissue in the retroperitoneal space, specifically originating from fibroblasts that produce collagen and other fibers forming the structural framework of connective tissues. The retroperitoneal space, located behind the peritoneum, contains various structures such as the kidneys, adrenal glands, pancreas, parts of the duodenum and colon, and major blood vessels like the aorta and inferior vena cava 1. Fibrosarcomas in this location develop from the fibrous supporting tissues surrounding these organs rather than from the organs themselves.

Key Characteristics of Retroperitoneal Fibrosarcoma

  • Characterized by the proliferation of malignant spindle-shaped cells that produce collagen
  • Typically present as large, solitary masses that can displace adjacent structures and cause symptoms through mass effect
  • The retroperitoneal location allows these tumors to grow quite large before causing noticeable symptoms, contributing to their often advanced stage at diagnosis 2

Importance of Accurate Diagnosis

An accurate diagnosis is necessary for correct management and prognostication of retroperitoneal sarcomas, including fibrosarcomas 3. The diagnostic approach involves careful consideration of the tumor's histologic findings and differential diagnoses. Recent developments in treatment, including neoadjuvant and adjuvant therapies, may improve local control and survival for patients with retroperitoneal fibrosarcoma 4.

Current Concepts in Management

Surgery is the mainstay of treatment for retroperitoneal sarcomas, with complete surgical resection being the primary goal 5. The technique of resection is standardized, and preoperative assessment of pathoanatomical growth patterns influences surgical strategies. Adjuvant and neoadjuvant treatment options, such as chemotherapy and radiation therapy, are being investigated to improve outcomes for patients with retroperitoneal fibrosarcoma.

References

Research

Current diagnosis and management of retroperitoneal sarcoma.

Cancer control : journal of the Moffitt Cancer Center, 2011

Research

Current concepts in the management of retroperitoneal soft tissue sarcoma.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.